- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
VVUS
4 Pharmaceutical Stocks to Sell Now
The ratings of four Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
It’s All About ‘Fruit’: Monday’s IP Market Recap
Corporate news in Dole, BlackBerry and Apple made the biggest headlines in an otherwise mixed day.
3 Pharmaceutical Stocks to Sell Now
This week, the overall grades of three Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
This week, the overall grades of three Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
4 Pharmaceutical Stocks to Sell Now
The ratings of four Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
This week, the overall grades of three Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Fed Keeps ‘Em Guessing: Wednesday’s IP Market Recap
Federal Reserve minutes that show a split among members regarding the Fed's easing policy helped lead stocks back up, as markets finished the day mixed
4 Pharmaceutical Stocks to Sell Now
The overall ratings of four Pharmaceutical stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Housing Helps Wall Street Mend: Tuesday’s IP Market Recap
Solid economic reports on housing, durable goods and consumer confidence sent stocks broadly ahead Tuesday, though BKS and WAG were among notable laggards.
3 Pharmaceutical Stocks to Sell Now
The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Wall Street Bristles at Big Ben: Wednesday’s IP Market Recap
Following news that the Fed planned on continuing its easing policies, Ben Bernanke indicated QE could be tapered by mid-2014, and stocks dropped off as a result.
Arena, Vivus Look Good (And It Has Nothing to Do With the AMA)
The AMA has ruled to classify obesity more intensely -- as a "disease." But are ARNA and VVUS investors justified in being excited?
